March 24, 2026
1 min read

WuXi Bio’s record number of new projects in 2025 leaned heavily on US clients

Despite policy uncertainties in recent years, WuXi Biologics’ emphasis on its U.S. operations continued to pay off in 2025, with the States accounting for a major portion of the record number of projects the CRDMO locked in last year.

Leave a Reply

Your email address will not be published.

Previous Story

Cheap Children’s Clothing Tainted With Lead, Study Says MedNews

Next Story

Study Warns Fluoride Bans May Raise Tooth Decay in Children MedNews

Previous Story

Cheap Children’s Clothing Tainted With Lead, Study Says MedNews

Next Story

Study Warns Fluoride Bans May Raise Tooth Decay in Children MedNews

Latest from Blog

Go toTop